Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Perspective

Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease

Author(s): Md. Sahab Uddin*

, Umme Tabassum Arobi Katha and Ghulam Md. Ashraf*

Volume 22, Issue 14, 2021

Published on: 09 March, 2021

Page: [1578 - 1584] Pages: 7

DOI: 10.2174/1389450122666210309105326

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

13

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Getting Rid of Intracellular Aβ - Loss of Cellular Degradation Leads to Transfer Between Connected Neurons
Current Pharmaceutical Design

Effect of Phosphorylation and Aggregation on Tau Binding to Dna
Protein & Peptide Letters

The Infectious Etiology of Alzheimer’s Disease
Current Neuropharmacology

Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Current Cancer Therapy Reviews

TRP Channels in Vascular Disorders
Current Topics in Medicinal Chemistry

Protective Effects of Isothiocyanates against Alzheimer's Disease
Current Traditional Medicine

Application of NMR to the Study of Cells and Body Fluids
Current Organic Chemistry

A Review on Extraction, Synthesis and Anticancer Activity of Betulinic Acid
Current Bioactive Compounds

The Bioanalytical Molecular Pharmacology of the N-methyl-<sub>D</sub>-Aspartate (NMDA) Receptor Nexus and the Oxygen-Responsive Transcription Factor HIF-1α : Putative Mechanisms and Regulatory Pathways Unravel the Intimate Hypoxia Connection
Current Molecular Pharmacology

Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued)

Cancer Neovascularization and Proinflammatory Microenvironments
Current Cancer Drug Targets

Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Current Medicinal Chemistry

Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists
Current Pharmaceutical Design

Ethanolamine: A Potential Promoiety with Additional Effects on the Brain
CNS & Neurological Disorders - Drug Targets

<i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds

Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Current Alzheimer Research

Characterization of LC-HCC Fusion Protein of Botulinum Neurotoxin Type A
Protein & Peptide Letters

Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications
Current Drug Targets

Preliminary Study on Major Phenolic Groups, Antioxidant and Cytotoxic Capacity of Tuckeroo (<i>Cupaniopsis Anacardioides</i>) Fruit Extracts
Current Nutraceuticals

Synthesis and Bioevaluation of Quaternary Centered 3-hydroxy-3 (alkynyl)indolin-2-one Derivatives as Potential Cytotoxic Agents and Akt Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry

© 2025 Bentham Science Publishers | Privacy Policy